APOE4 gene linked to early onset Alzheimer’s, target for therapeutic intervention

FHS
May 8, 2024
5:20 am

A study published in Nature Medicine delineates how APOE4 homozygosity distinctly accelerates Alzheimer’s disease pathology and biomarkers from the age of 55, suggesting a unique form of the disease and a potential focus for targeted therapies.

Study finds major gaps in cancer screening use in Federally Qualified Health Centers

A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center

April 29, 2024

Cholinesterase inhibitors may slow cognitive decline in dementia with Lewy bodies

Dementia with Lewy bodies is a type of dementia that is similar to both Alzheimer’s disease and Parkinson’s disease but studies on long-term treatments are

August 23, 2024

Frailty Worsens Side Effects of Rheumatoid Arthritis Treatment

Patients starting targeted therapies for rheumatoid arthritis (RA) were more likely to develop serious infections and other adverse events if they were considered frail, insurance

December 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.